EUVIMEDOpdag EUVIMED
Kontrollierte klinische StudieMultizentrische Studie

Platelet‐Rich Plasma for Treating COVID‐19‐Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study

Jerome R Lechien, Sven Saussez

Otolaryngology–Head and Neck Surgery · 2025

DOI: 10.1002/ohn.1149 ↗

At a glance

Kontrollierte klinische Studie in Otolaryngology–Head and Neck Surgery, 2025. Written by Jerome R Lechien and 1 co-authors. Institution: Department of Otolaryngology, Polyclinic of Poitiers, Elsan, Poitiers, France. Major MEDLINE topics: Anosmia, COVID-19, Olfaction Disorders, Platelet-Rich Plasma. Cited 7 times so far (Crossref); 39 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

To investigate the effectiveness of platelet‐rich plasma (PRP) injection into the olfactory clefts of coronavirus disease 2019 (COVID‐19) patients with persistent anosmia, hyposmia, and parosmia. Study Design Controlled study.

Setting

Multicenter study.

Methods

From March 2022 to July 2024, 514 COVID‐19 patients undergoing PRP injection and olfactory training versus olfactory training (controls) for a persistent olfactory dysfunction (OD) were consecutively recruited from two medical centers. Subjects were evaluated from pre‐ to 3 months post‐injection with the olfactory disorder questionnaire (ODQ) and the threshold, discrimination, and identification (TDI) test. Olfactory outcomes were compared between controls and patients considering the type of OD (anosmia, hyposmia, and parosmia).

Results

The PRP group was composed of 416 patients with anosmia (N = 111; 26.7%), hyposmia (N = 160; 38.5%), and parosmia (N = 145; 34.9%). The baseline ODQ of patients with parosmia was significantly higher than those of the other groups ( P = .001). The increase in TDI subscores and total score was significantly higher in all PRP subgroups compared to controls ( P = 0.001). The ODQ significantly reduced from pre‐ to post‐PRP injection in hyposmia and parosmia groups ( P = 0.001). Patients with parosmia showed a significantly greater reduction in ODQ scores compared to the control group. The 3‐month TDI score was negatively influenced by the age of patients ( r s = −0.263; P = 0.001) and the duration of OD ( r s = −0.213; P = .001).

Conclusion

Patients with parosmia experienced a stronger impact of OD on quality of life (QoL), and showed greater QoL improvement following PRP injections compared to other groups.

Subjects

MeSH terms (MEDLINE)

AnosmiaCOVID-19Olfaction DisordersPlatelet-Rich PlasmaAdultAgedFemaleHumansMaleMiddle AgedLongitudinal StudiesSARS-CoV-2Treatment Outcome

Author keywords

COVID‐19SARS‐CoV‐2anosmiahyposmiaolfactoryotolaryngologyotorhinolaryngologyparosmiaplatelet‐rich plasmarecoveryrhinologysmell

Authors and institutions

  • Department of Otolaryngology, Polyclinic of Poitiers, Elsan, Poitiers, France.
  • Department of Surgery, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.
  • Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, School of Medicine, UFR Simone Veil, Université Versailles Saint-Quentin-en-Yvelines (Paris Saclay University), Paris, France.
  • Department of Otorhinolaryngology and Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.
  • Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Cite

APA

Lechien, J. R., & Saussez, S. (2025). Platelet‐Rich Plasma for Treating COVID‐19‐Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1149

Vancouver

Lechien JR, Saussez S. Platelet‐Rich Plasma for Treating COVID‐19‐Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1149

BibTeX
@article{Lechien2025,
  author = {Lechien, Jerome R and Saussez, Sven},
  title = {Platelet‐Rich Plasma for Treating COVID‐19‐Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  doi = {10.1002/ohn.1149}
}
Start for free →